Related Experiment Video
Updated: Jun 14, 2026
A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV
Maria Soledad Alvarez1, Estefanía Núñez2,3, Marina Fuertes-Agudo1,4
1Instituto de Biomedicina de Valencia (IBV), CSIC, Jaume Roig 11, 46010 Valencia, Spain.
Abstract:
The biochemical mechanisms of cell injury and myocardial cell death after myocardial infarction remain unresolved. Cyclooxygenase 2 (COX-2), a key enzyme in prostanoid synthesis, is expressed in human ischemic myocardium and dilated cardiomyopathy, but it is absent in healthy hearts. To assess the role of COX-2 in cardiovascular physiopathology, we developed transgenic mice that constitutively express functional human COX-2 in cardiomyocytes under the control of the α-myosin heavy chain promoter. These animals had no apparent phenotype but were protected against ischemia-reperfusion injury in isolated hearts, with enhanced functional recovery and diminished cellular necrosis. To further explore the phenotype of this animal model, we carried out a differential proteome analysis of wild-type vs. transgenic cardiomyocytes. The results revealed a tissue-specific proteomic profile dominated by mitochondrial proteins. In particular, an increased expression of respiratory chain complex IV proteins was observed. This correlated with increased catalytic activity, enhanced respiratory capacity, and increased ATP levels in the heart of COX-2 transgenic mice. These data suggest a new link between COX-2 and mitochondria, which might contribute to the protective cardiac effects of COX-2 against ischemia-reperfusion injury.
Insights
Cyclooxygenase 2 (COX-2) expression in the heart protects against ischemia-reperfusion injury. Transgenic mice with COX-2 showed improved cardiac function and reduced cell death, linked to enhanced mitochondrial activity.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Mitochondrial Physiology
Background:
- Mechanisms of myocardial cell injury post-infarction are unclear.
- Cyclooxygenase 2 (COX-2) is upregulated in ischemic heart conditions but absent in healthy hearts.
- The role of COX-2 in cardiovascular pathophysiology requires elucidation.
Purpose of the Study:
- To investigate the role of COX-2 in cardiovascular physiopathology.
- To assess the protective effects of COX-2 against myocardial ischemia-reperfusion injury.
- To explore the molecular mechanisms underlying COX-2-mediated cardioprotection.
Main Methods:
- Development of transgenic mice expressing human COX-2 in cardiomyocytes.
- Assessment of cardiac function and injury in isolated hearts subjected to ischemia-reperfusion.
- Differential proteome analysis of wild-type versus COX-2 transgenic cardiomyocytes.
- Measurement of mitochondrial respiratory chain complex activity and ATP levels.
Main Results:
- COX-2 transgenic mice exhibited enhanced recovery and reduced necrosis after ischemia-reperfusion.
- Proteomic analysis revealed increased expression of mitochondrial proteins, particularly respiratory chain complex IV.
- Increased COX-2 expression correlated with enhanced mitochondrial respiratory capacity and ATP production.
- Transgenic hearts showed increased catalytic activity in respiratory chain complexes.
Conclusions:
- Constitutive expression of COX-2 in cardiomyocytes confers protection against ischemia-reperfusion injury.
- COX-2 influences cardiac mitochondrial function, enhancing respiratory capacity and ATP levels.
- A novel link between COX-2 and mitochondrial protection in the heart is suggested.
- COX-2 may represent a therapeutic target for mitigating cardiac injury.
More Related Videos
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
07:03Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics
Published on: August 23, 2024
